<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>The Neuroscience Journal of Shefaye Khatam</title>
<title_fa>مجله علوم اعصاب شفای خاتم</title_fa>
<short_title>Shefaye Khatam</short_title>
<subject>Medical Sciences</subject>
<web_url>http://shefayekhatam.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-1887</journal_id_issn>
<journal_id_issn_online>2345-4814</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/shefa</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>fa</language>
<pubdate>
	<type>jalali</type>
	<year>1396</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2017</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<volume>5</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa>P 144: Sunflower Mannose binding Lectin-Associated Serine Protease Inhibitor-1 (SFMI-1) and -2: Significant Inhibitors of Mannose binding Lectin Pathway which Helps in Multiple Sclerosis Treatment</title_fa>
	<title>P 144: Sunflower Mannose binding Lectin-Associated Serine Protease Inhibitor-1 (SFMI-1) and -2: Significant Inhibitors of Mannose binding Lectin Pathway which Helps in Multiple Sclerosis Treatment</title>
	<subject_fa>تحقیقات پایه در علوم اعصاب</subject_fa>
	<subject>Basic research in Neuroscience</subject>
	<content_type_fa>مروری</content_type_fa>
	<content_type>Review --- Open Access, CC-BY-NC</content_type>
	<abstract_fa>&lt;table border=&quot;0&quot; cellpadding=&quot;5px&quot; cellspacing=&quot;2&quot; dir=&quot;rtl&quot; id=&quot;table_article&quot; style=&quot;font-family: Tahoma; background-color: rgb(251, 250, 249); break-inside: avoid !important;&quot; width=&quot;100%&quot;&gt;
	&lt;tbody style=&quot;break-inside: avoid !important; font-size: 12px; margin-top: 0px; line-height: 2.2; margin-bottom: 0px; text-align: justify;&quot;&gt;
		&lt;tr style=&quot;break-inside: avoid !important;&quot;&gt;
			&lt;td class=&quot;abstractmed&quot; colspan=&quot;2&quot; style=&quot;break-inside: avoid !important;&quot;&gt;
			&lt;p style=&quot;font-size: 12px; margin-top: 0px; margin-bottom: 0px; text-align: center;&quot;&gt;&lt;span style=&quot;color: rgb(0, 0, 0); font-size: 12px; line-height: 20.8px;&quot;&gt;لطفاً به چکیده انگلیسی مراجعه شود.&lt;/span&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style=&quot;break-inside: avoid !important;&quot;&gt;
		&lt;/tr&gt;
	&lt;/tbody&gt;
&lt;/table&gt;

&lt;p&gt;&lt;/p&gt;
</abstract_fa>
	<abstract>&lt;p&gt;One of the important parts of innate immunity is complement system that occurs in three different ways; the classic, the alternative and the lectin pathway. The four pattern recognition molecules that have been identified till now are Mannose binding lectin (MBL), a component of lectin pathway, and three ficolins (ficolin1,-2 and -3) which compound to the carbohydrates of the cell surface. MBL associated serine protease1 (MASP-1), MASP-2 and -3 are three proteases which associate with recognition molecules. Also MBL-associated protein 19 and MBL-associated protein 44 are two non-catalytic molecules that their role is association with recognition molecules. MASP-1 and MASP-2 activate the lectin pathway but function of MASP-3 is unclear. Although some researches show that MASP-3 down regulates activation of two other MASPs and has a similar role like MBL-association 19 and MBL-association 44 that they inhibit MBL pathway too. Researches show that MBL pathway has a critical role in pathogenesis of autoimmune diseases such as multiple sclerosis (MS). Researches indicate that levels of MBL pathway activator components (MASP-1 and MASP-2) are higher in serum plasma of MS patients. Inhibiting activators of MBL pathway seems to be useful for MS treatment and reducing its disabilities. Sunflower MASP inhibitor-1 (SFMI-1) and sunflower MASP inhibitor-2 (SFMI-2) are two peptides with 14 amino acids that inhibit MASP-1 and MASP-2 and block the lectin pathway activation. This article suggests using SFMI-1 and SFMI-2 in drugs to targeted therapy of MS and decreasing its symptoms.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Mannose-binding lectin, Mannose-binding lectin-associated serine protease (MASP), Multiple sclerosis </keyword>
	<start_page>175</start_page>
	<end_page>175</end_page>
	<web_url>http://shefayekhatam.ir/browse.php?a_code=A-10-24-995&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Pouya </first_name>
	<middle_name></middle_name>
	<last_name>Ghaderi</last_name>
	<suffix></suffix>
	<first_name_fa>Pouya </first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Ghaderi</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>pouyaghaderi73@gmail.com</email>
	<code>100319475328460012208</code>
	<orcid>100319475328460012208</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Islamic Azad University, Mashhad Branch, Mashhad, Iran</affiliation>
	<affiliation_fa>Islamic Azad University, Mashhad Branch, Mashhad, Iran</affiliation_fa>
	 </author>


	<author>
	<first_name>Hamed </first_name>
	<middle_name></middle_name>
	<last_name>Delfaraz</last_name>
	<suffix></suffix>
	<first_name_fa>Hamed </first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Delfaraz</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012209</code>
	<orcid>100319475328460012209</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Islamic Azad University, Mashhad Branch, Mashhad, Iran</affiliation>
	<affiliation_fa>Islamic Azad University, Mashhad Branch, Mashhad, Iran</affiliation_fa>
	 </author>


	<author>
	<first_name>Mohaddese </first_name>
	<middle_name></middle_name>
	<last_name>Ahmadabadi</last_name>
	<suffix></suffix>
	<first_name_fa>Mohaddese </first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Ahmadabadi</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012210</code>
	<orcid>100319475328460012210</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Islamic Azad University, Mashhad Branch, Mashhad, Iran</affiliation>
	<affiliation_fa>Islamic Azad University, Mashhad Branch, Mashhad, Iran</affiliation_fa>
	 </author>


	<author>
	<first_name>Mahdiye </first_name>
	<middle_name></middle_name>
	<last_name>Ehsani</last_name>
	<suffix></suffix>
	<first_name_fa>Mahdiye </first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Ehsani</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012211</code>
	<orcid>100319475328460012211</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Islamic Azad University, Mashhad Branch, Mashhad, Iran</affiliation>
	<affiliation_fa>Islamic Azad University, Mashhad Branch, Mashhad, Iran</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
